Interactions between cytadren(aminoglutethimide) and Anisindione (anisindione)
anisindione and aminoglutethimide (Moderate Drug-Drug)
MANAGEMENT: The patient should be monitored for reduced anticoagulant effect when aminoglutethimide is added, discontinued, or the dosage is changed. Patients should be advised to promptly report any signs of blood clots (e.g. chest pain, shortness of breath, sudden loss of vision, or pain, redness or swelling in an extremity).






